The road to the commercial contraceptive market is a “constant battle,” admits Michael O’Rand, Ph.D. For nearly a decade, O’Rand’s company Eppin Pharma Inc. has been traveling the long and expensive path of developing a drug that has the potential to completely transform family planning: a male birth control pill. “It costs hundreds of millions of dollars